GFL weighs sale in infrastructure arm valued at C$5 billion
Investing.com -- Gfl Environmental (TSX:GFL) Holdings Inc (NYSE:GFL) is exploring the sale of a stake in its infrastructure arm, Green Infrastructure Partners Inc., in a potential deal that could value the business at around C$5 billion ($3.7 billion) including debt, Bloomberg reported, citing people familiar with the matter. The development underscores growing investor interest in Canadian civil infrastructure as major funds line up to participate.
The Markham, Ontario-based company has held early-stage talks with private equity firms including General Atlantic, Energy Capital Partners (WA:CPAP), and Neuberger Berman, the people said. The transaction, if completed, would mark one of the largest infrastructure-related deals in Canada this year.
Green Infrastructure Partners operates separately from GFL's core solid waste and environmental services business, providing services such as road building, paving, and site development. The unit has grown rapidly in recent years through a series of acquisitions, making it a strategic asset in Canada's expanding civil infrastructure sector.
For GFL, the sale of a stake would unlock capital to support Green Infrastructure Partners' continued expansion while monetizing a high-growth division. The move comes amid strong private capital flows into infrastructure, with investors broadly seeking stable cash-generating assets amid market volatility.
Shareholders of GFL, including HPS Investment Partners, are involved in the ongoing discussions, though no final decisions have been made. The structure, size, and timing of any potential sale remain under consideration.
While the process is still in its early stages, additional interest from other strategic or financial bidders is possible, said sources. A transaction would mark another significant portfolio reshuffle by GFL as the company refines its long-term strategic focus.
Related articles
GFL weighs sale in infrastructure arm valued at C$5 billion - Bloomberg
Tesla shares gain as Trump wishes Musk 'well'
Apple's WWDC called a 'yawner' amid delayed AI progress
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
27 minutes ago
- Yahoo
MedX Announces Final Closing of Non-Brokered Private Placement
MISSISSAUGA, Ontario, June 09, 2025--(BUSINESS WIRE)--MedX Health Corp. ("MedX" or the "Company") (TSX-V: MDX) is pleased to announce that, further to its Press Releases dated April 7, and May 22, 2025, announcing an Initial Closing and further Closing, it has completed a final Closing of the Non-brokered Private Placement to accredited investors originally announced in its Press Release dated February 25, 2025. The Final Closing comprised the issuance of 8,678,571 Units (as described below) and raised cash proceeds of $607,500, bringing the total amount raised in the Placement to $2,063,500. Securities issued are subject to a regulatory "hold" period of four months and one day from the date of issuance. Under this Non-Brokered Private Placement, the Company issued a total of 29,478,571 Units at $0.07 per Unit ("Unit"). Each Unit is comprised of One (1) fully paid common share and One (1) Share Purchase Warrant ("Warrant(s)"), exercisable to purchase One (1) further Common Share at the price of $0.09, during the period of one year commencing on the date of issuance. Three Insiders participated in this Placement to the extent of $500,000, for the acquisition of a total of 7,142,857 Units. In connection with the issuance of Units to those Insiders, the Company relies on exemptions from formal valuation and minority shareholder approval requirements set out in Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions ("MI 61-101"). as (i) the fair market value of the proposed placement to the Insiders does not exceed 25% of the market capitalization of the Company and (ii) the conditions in section 5.7(1)(a), section 5.7(1)(b) and section 5.7(1)(e) of MI 61-101 are met. Qualified agents received total cash commissions of $15,880, (equal to 8% of the gross proceeds received by the Company from the sale of the Units to subscribers introduced by such agent(s)), and 226,857 agent's warrants ("Agent's Warrant(s)") (equal to 8% of subscriptions introduced by such agent(s)). Each Agent's Warrant, which is non-transferable, entitles the holder to acquire, at the price of CAD$0.07, a unit, comprised of One (1) fully paid Common Share and one (1) non-transferable share purchase warrant ("Agent's Share Purchase Warrant"), entitling the holder to acquire one additional Common Share at the price of CAD$0.09. The Agent's Warrants and any Agent's Share Purchase Warrants that may be issued pursuant to exercise of an Agent's Warrant, if not exercised, will expire one year following the date of issuance. Funds raised in this Placement are being be directed towards continuing development of the Company's leading edge SIAscopy® on DermSecure® telemedicine platform, building out the launch of its technology into the occupational health marketplace, and general corporate purposes. About MedX Health Corp.: MedX, headquartered in Ontario, Canada, is a leading medical device and software company focused on skin health with its SIAscopy® on DermSecure® telemedicine platform, utilizing its SIAscopy® technology. SIAscopy® is also imbedded in its products SIAMETRICS®, SIMSYS®, and MoleMate®, which MedX manufactures in its ISO 13485 certified facility. SIAMETRICS®, SIMSYS®, and MoleMate® include hand-held devices that use patented technology utilizing light and its remittance to view up to 2 mm beneath suspicious moles and lesions in a pain free, non-invasive manner, with its software then creating real-time images for physicians and dermatologists to evaluate all types of moles or lesions within seconds. These products are cleared by Health Canada, the U.S. Food and Drug Administration, the Therapeutic Goods Administration and Conformité Européenne for use in Canada, the U.S., Australia, New Zealand, the European Union and Turkey. Visit Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. This Media Release may contain forward-looking statements, which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties. View source version on Contacts MedX Health Druhan, President, Dermatological (+1) 905-599-7852
CNBC
36 minutes ago
- CNBC
Trump to keep Starlink at White House despite break with Elon Musk
President Donald Trump said on Monday he has no plans to discontinue Starlink at the White House but might move his Tesla off-site, following his announcement over the weekend that his relationship with Elon Musk, the billionaire CEO of both companies, was over. "I may move the Tesla around a little bit, but I don't think we'll be doing that with Starlink. It's a good service," Trump told reporters, referring to the satellite internet company that provides high-speed broadband access. It is a unit of Musk's SpaceX. In March, Trump said he had purchased a red Tesla Model S from Musk, Trump's then-close ally. Last week, a White House official said Trump might get rid of it after a public feud erupted between the two men. The Tesla was seen parked at the White House over the weekend. On Saturday, Trump said he had no intention of repairing ties with Musk. On Monday, the president said he would not have a problem if Musk called. "We had a good relationship, and I just wish him well," Trump said. Musk responded with a heart emoji to a video on X showing Trump's remarks. Last week, Trump and Musk exchanged a flurry of insults after the world's richest man denounced Trump's tax and spending bill as a "disgusting abomination." Musk's opposition has complicated Republican efforts to pass Trump's "big, beautiful bill" in Congress, where the party holds slim majorities in the House of Representatives and Senate. Since the dispute began last Thursday, Musk has deleted some social media posts critical of Trump, including one signaling support for impeaching the president. Sources close to Musk said his anger has started to subside, and they believe he may want to repair his relationship with Trump.
Yahoo
42 minutes ago
- Yahoo
America's $75 Billion Nuclear Bet: Westinghouse vs. the Future of Energy
Westinghouse is going all-in on America's nuclear revival. Backed by Brookfield and Cameco, the Pennsylvania-based firm is in active talks with US officials, tech firms, and utilities to build 10 large nuclear reactors under President Trump's new energy directive. The order sets a 2030 deadline to begin construction and aims to quadruple US nuclear output by 2050. That kind of ambition could translate into a $75 billion opportunity, based on Department of Energy cost estimates. Interim CEO Dan Sumner says Westinghouse has the edgeits AP1000 design is approved, the supply chain is intact, and it's already delivered units in the US and China. We believe we can do them all, Sumner told the FT, pointing to hyperscaler interest and government loan programs as signs of momentum. Warning! GuruFocus has detected 2 Warning Sign with AMZN. But it's not a done deal yet. Nuclear still faces stiff economic headwinds in the US. While Washington may be on board, local utilities and regulators still have the final sayand memories of the Vogtle project's ballooning costs still linger. Analysts warn that the current US power market structure doesn't guarantee cost recovery for mega-projects, making investor appetite uncertain. Even so, Sumner argues that lessons from past delays have been baked into the new build model: We're the only ones who've done modular nuclear at scale. And now, the learning's embedded. Meanwhile, SMR developers aren't staying quiet. NuScale is pitching a 12-pack of its 77MW modules to rival traditional plants in capacity, while Holtec's 320MW units could be grouped to matchand beatWestinghouse on cost and complexity. We fully intend to compete with the big plants, Holtec's president said. The big question now: Will deep-pocketed buyersthink Amazon (NASDAQ:AMZN), Google (NASDAQ:GOOG), Microsoft (NASDAQ:MSFT)step up to fund these nuclear ambitions, or wait for the small guys to scale first? Either way, the race is on. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
